Irrespective of the lack of transport improvement, neither NT-3 nor VEGF165 treatment results in complete rescue of neuropathy (11, 68), indicating that alternative therapeutic strategies are required to treat this disease and that a combinatorial approach including BDNF may produce the greatest phenotypic improvements. This evidence concerns the gene NTF3 and neuropathy.